on IKONISYS (EPA:ALIKO)
Hospitex Pioneers Oncology Diagnostic Projects in Asia
Paris, November 24, 2025 – Hospitex, an Italian subsidiary of Aliko Scientific, announced pilot projects for its Urine24 diagnostic kit in the Far East. This move follows the Asian Development Bank's delegation visit, part of a Health Study Tour facilitated by the Italian Ministry of Economy and Finance.
The delegation visit aimed to showcase Hospitex's diagnostic platforms, including the scalable Urine24 kit for early detection of urinary tract cancers. It attracted interest from health representatives from Thailand, the Philippines, Uzbekistan, and Tajikistan, showing promise for implementation in emerging markets.
These projects mark a step forward in technology-driven diagnostics, highlighting Hospitex's commitment to international healthcare innovation. Support from the Development Bank indicates institutional recognition of Hospitex's advancements in oncology diagnostics.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all IKONISYS news